“Dealing with people, not patients”: Pharma leaders warn of dangers of overpromising microbiome innovation at Future Food-Tech

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

23 Sep 2020 --- One year into the establishment of Cargill Health Technologies (CHT), the division is spearheading R&D in the fledgling postbiotic ingredient category.... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

22 Sep 2020 --- Biosearch Life has obtained its first organic certification for L. fermentum LC40 strain in its Hereditum portfolio. This certification allows consumers to... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

21 Sep 2020 --- The DuPont Human Microbiome Venture is partnering with The Procter & Gamble Company (P&G) to develop next-generation probiotics (NGPs) for human health. The... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

18 Sep 2020 --- As industry strides toward a better understanding of the gut microbiome, clear scientific and pharmaceutical standards are needed for live biotherapeutic products... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

18 Sep 2020 --- Lonza is launching its first probiotic ingredient for the sports nutrition market. TWK10 is a Lactobacillus plantarum probiotic strain that has been clinically... Read More

trans